Evidence map›Paper›PMID 34101973›Full record

ArticleJournal of thrombosis and haemostasis : JTH2021

The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination.

Micol G Cittone, Raphael Battegay, Adalgisa Condoluci, Lodovico Terzi di Bergamo, Eliana Fernandes, Elena Galfetti, Roberta Noseda, Anne Leuppi-Taegtmeyer, Beatrice Drexler, Alessandro Ceschi and 8 more

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Micol G CittoneClinic of Hematology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Raphael BattegayDivision of Hematology, University Hospital Basel, Basel, Switzerland.
Adalgisa CondoluciClinic of Hematology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Lodovico Terzi di BergamoInstitute of Oncology Research (IOR), Bellinzona, Switzerland.
Eliana FernandesClinic of Hematology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Elena GalfettiClinic of Hematology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Roberta NosedaDivision of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, EOC, Lugano, Switzerland.
Anne Leuppi-TaegtmeyerRegional Pharmacovigilance Centre, Department of Clinical Pharmacology and Toxicology, University Hospital Basel, University of Basel, Basel, Switzerland.
Beatrice DrexlerDivision of Hematology, University Hospital Basel, Basel, Switzerland.
Alessandro CeschiDivision of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, EOC, Lugano, Switzerland.
Dimitrios A TsakirisDivision of Hematology, University Hospital Basel, Basel, Switzerland.
Christoph T BergerTranslational Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Genevieve FavreDivision of Hematology, Cantonal Hospital Liestal, Liestal, Switzerland.
Thomas MartinHemophilia and Hemostasis Center, Centre for Laboratory Medicine, St. Gallen, Switzerland.
Wolfgang KorteHemophilia and Hemostasis Center, Centre for Laboratory Medicine, St. Gallen, Switzerland.
Lukas GrafHemophilia and Hemostasis Center, Centre for Laboratory Medicine, St. Gallen, Switzerland.
Maria MartinezDepartment of Diagnostic Hematology, University of Basel, Basel, Switzerland.
Bernhard GerberClinic of Hematology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Institute of Oncology Research · CHUniversity Hospital of Basel · CHUniversity of Basel · CHUniversity of St.Gallen · CHLaboratory for Biomedical Neurosciences · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Hemophilia AHumansSARS-CoV-2Vaccinationacquired hemophilia AAHACOVID-19hemostasisSARS-CoV-2 vaccine

Identifiers

PMID34101973
PMCPMC9771119
OpenAlexW3171436725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.